Yuasa Co. Ltd. · TSE:8074
Yuasa — Q2 FY2017.3 Earnings Presentation
27 slides from Yuasa's earnings presentation, November 2016
Slide 1: Yuasa Q2 FY2017.3 results briefing
W avvmeactan YUASA
Slide 2: 1
1
Slide 3: 2
2
Slide 4: 3
3
Slide 5: 4
4
Slide 6: 5
5
Slide 7: 6
6
Slide 8: Genie
Genie 7
Slide 9: 8
8
Slide 10: a79 @aynyav7
a79 @aynyav7
Slide 11: 10
10
Slide 12: 11
11
Slide 13: 12
12
Slide 14: 13
13
Slide 15: ree & as
i ree & as [a z. A gy A 4 ££ ee tO oe coo ae W arvana YUASA
Slide 16: 15
15
Slide 17: 500,000 12,500 2.5% 400,000 10,000 2.0% 300,000 7,500 1.5% 200,000 5,000 1.0% 100,000 2,500
500,000 12,500 2.5% 2 2 400,000 10,000 2.0% 300,000 7,500 1.5% 200,000 5,000 1.0% 100,000 2,500 0.5% 0 0 0.0% 2012.3 2013.3 2014.3 2015.3 2016.3 2012.3 2013.3 2014.3 2015.3 2016.3 12,500 3.0% 8,000 2 2 2.5% 10,000 6,000 2.0% 7,500 1.5% 4,000 5,000 1.0% 2,000 2,500 0.5% 0 0.0% 0 2012.3 2013.3 2014.3
Slide 18: 20.0 28.0 27.96 50,000 18.0 45,000 26.0 16.0 15.58 25.45 40,000 14.94 13.21 14.0
20.0 28.0 27.96 50,000 18.0 45,000 26.0 16.0 15.58 25.45 40,000 14.94 13.21 14.0 24.0 13.49 13.42 35,000 34,947 12.0 32,357 22.0 30,000 10.0 21.42 25,000 8.0 20.0 22,296 19.14 20,000 6.0 18.0 15,000 4.0 16.88 11,935 16.0 10,000 2.0 5,000 4,972 0.0 14.0 2012.3 2013.3 2014.3 2015.3 2016.3 2012.3 2013.
Slide 19: Say
Say <pRBNREETHME [YUASA LEGACY 350)CDWT RRDDOSAS = a 410 eee 4773-Emes ot 382 anita mmm 41018 at) 7, = Be BADRLS 9.2% Tear) 240 wrcs-nmm |e a A3s +5 , 7 mes Lick ek. 777 co L PERE RERRTE OIL = sor co RAH BIRR SAOMA 2015/3 —-2016/3 2017/3 p77 ol * (2D (HD 18
Slide 20: cpa [YUASA LEGACY 350) [c WT RROVORAEE
cpa [YUASA LEGACY 350) [c WT RROVORAEE : Fai RRS LA)DF—BeR 60018 wmOwmA BIL (ABH BS) ROMS HB-B O ARs (Lis iB) 2015/3 fee] 2016/3 (a) 2017/3 ASA [ZEHItea—2 757 19
Slide 21: RO RR same
RO RR same = i) 1 Aaah L + SF Tess al oR 1G : = 121 atacand LYVUIYABRALS RSF 10 ite 4yIF 19 — cd AN-K(LDYULYARBR)EYIZ bh (BCP3i8. BES) OM ICRU ERO - MK - BCPA HERBLET. 92 r LYVLIY AA MOME BCP. itm (biess (P+ Biases) a, 122 17 96 2016/3 ee) 150 er) 10 = 20 58 (2Q44) = 120 47 (2017/3 20
Slide 22: 2m) APH PRERRB2—4-12 AP+ARE IOS
2m) APH PRERRB2—4-12 AP+ARE IOS =) SLR BRR RUABARRS AT LOM 102% (20167A) 985A fy) 67187 (201 S998) an RE 20167208 De- BAERS 2m) TRGB RA SU 7 17-12 eh PHRMA OMRASRRU IY VIF UY TSM 2) 21% (20169) a) 50BAR Li) 220879 (20151278) ssh) 2016810838 21
Slide 23: {PRBEERNEIYUASA LEGACY 350)(c WT
{PRBEERNEIYUASA LEGACY 350)(c WT tz icine E BRC<SULOMETIYbKIA—-A LP Sea S RAE 7 — tee) 2016 5 AICI TVR SS RMRL YS —HRMEPIUCLELE. FOAOYAT TIA PAAHRICORRHEELL. MRRBOSSCSRILEGNDTHVES. BON SRBE BEAL TH402, BT YI-F IY YP SERUM L, BROWAMAOMSIC FU, BPEORUBRHERNLTUIES. SRGVMARESROREC COBH SIEBRE< SLORMBTIY
Slide 24: |
| 23
Slide 25: Sarat
2 Sarat pi i rae
Slide 26: |
| 25
Slide 27: |
| 26